Protagonist Therapeutics
PTGX
#3747
Rank
C$3.83 B
Marketcap
$64.31
Share price
-2.90%
Change (1 day)
200.87%
Change (1 year)

EPS for Protagonist Therapeutics (PTGX)

EPS in 2023 (TTM): -$3.62

According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.73. In 2022 the company made an earnings per share (EPS) of -$3.62 an increase over its 2021 EPS that were of -$3.76.

EPS history for Protagonist Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.620.04%
2022-$3.62-3.7%
2021-$3.7635%
2020-$2.78-33.33%
2019-$4.1774.42%
2018-$2.39-20.74%
2017-$3.02-45.64%
2016-$5.5557.3%
2015-$3.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.03-18.66%๐Ÿ‡บ๐Ÿ‡ธ USA